Oral Peptide Therapeutics – Technologies have been honed to overcome many of the challenges of administering peptide therapeutics orally, but obstacles remain before drug developers can fully realize the vast potential.
Numerous technologies are currently in development that are designed to enable the oral delivery of peptides. Though each has its unique set of properties and capabilities, all must overcome key obstacles to successfully deliver peptides via the oral route.
This week’s available download is titled “Novel Approaches for Enhancing the Oral Bioavailability & Absorption of Peptides” from Rebecca Nofsinger at Merck. This presentation discusses peptide advantages and challenges, permeation enhancers and models to evaluate permeation limitations in oral absorption.
Scroll through the presentation below….
2023 Global Drug Bioavailability Enhancement Summit
(May 16-17, 2023, Princeton, NJ)